Literature DB >> 229789

Immunogenicity of subviral herpes simplex virus preparations. I. Formation of neutralizing antibodies in different animal species after administration of herpes simplex virus solubilized antigens.

L Kutinová, V Slichtová, V Vonka.   

Abstract

Production of neutralizing antibodies was followed in guinea pigs, rabbits, hamsters and mice immunized with crude antigen extracts (AM) from human diploid cells infected with herpes simplex virus type 1. The AM induced relatively high levels of neutralizing antibodies in all four species. The antibodies were predominantly complement-requiring and remained so even after administration of repeated AM doses. With the strains used, the antibody response was predominantly type specific and, surprisingly, the type specificity of sera usually increased after administration of repeated doses of AM. Guinea pigs seemed to be the best responsive animal species. They developed the highest levels of antibodies and complement-nonrequiring antibodies were seen in them earlier than in the other animal species. The dose-response experiments carried out in guinea pigs indicated that after a single dose administration the ratio between complement-requiring and complement-nonrequiring antibodies was dependent on the amount of antigen administered. When AM was given without adjuvant less efficient antibody production wws observed than after the administration of the same amount of antigen with adjuvant.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229789     DOI: 10.1007/bf01320598

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Production and some properties of neutralizing antigens of herpes simplex virus.

Authors:  L Kutinová; V Vonka; D Rezácová
Journal:  Acta Virol       Date:  1977-05       Impact factor: 1.162

2.  A PROTECTIVE ANTIGEN FROM THE POX-VIRUSES. II. IMMUNISATION OF ANIMALS.

Authors:  G APPLEYARD; J C WESTWOOD
Journal:  Br J Exp Pathol       Date:  1964-04

3.  STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. I. APPEARANCE OF NEUTRALIZING ANTIBODIES HAVING DIFFERENT GRADES OF COMPLEMENT REQUIREMENT.

Authors:  K YOSHINO; S TANIGUCHI
Journal:  Virology       Date:  1965-05       Impact factor: 3.616

4.  Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations.

Authors:  R Cappel
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

5.  Experiences in a long-term cultivation of own human diploid cell strains in synthetic medium with growth promoting proteins.

Authors:  D Rezácová; Z Baresová
Journal:  Prog Immunobiol Stand       Date:  1967

6.  Preparation of antisera against the S antigen of influenza A virus by immunization of guinea pigs with internal S antigen.

Authors:  H Závadová; L Kutinová; V Vonka
Journal:  Arch Gesamte Virusforsch       Date:  1967

7.  Herpes simplex vaccines.

Authors:  M R Hilleman
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

8.  Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.

Authors:  E N Kitces; P S Morahan; J G Tew; B K Murray
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

9.  Determination of virus-specific antigens in extracts from herpes simplex virus-infected cells by a Cr release inhibition test.

Authors:  L Kutinová; V Vonka
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

  9 in total
  6 in total

Review 1.  The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Immunogenicity of subviral herpes simplex virus type 1 preparation: protection of mice against intradermal challenge with type 1 and type 2 viruses.

Authors:  V Slichtová; L Kutinová; V Vonka
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2.

Authors:  M Bröker; K J Abel; R Köhler; J Hilfenhaus; E Amann
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

4.  Failure of a subunit bovine herpesvirus 1 vaccine to protect against experimental respiratory disease in calves.

Authors:  C L Darcel; K W Jericho
Journal:  Can J Comp Med       Date:  1981-01

Review 5.  Prospects and perspectives for development of a vaccine against herpes simplex virus infections.

Authors:  Shane C McAllister; Mark R Schleiss
Journal:  Expert Rev Vaccines       Date:  2014-07-31       Impact factor: 5.217

6.  Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.

Authors:  R J Klein; E Buimovici-Klein; H Moser; R Moucha; J Hilfenhaus
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.